Characteristics of ambulatory blood pressure parameters and influencing factors of untreated hypertensive patients at high and low altitudes: a cross-sectional study in China

中国高低海拔地区未治疗高血压患者动态血压参数特征及影响因素的横断面研究

阅读:1

Abstract

OBJECTIVES: Individuals in high-altitude areas (HAs) have a relatively high prevalence of hypertension. However, only a few studies have reported the out-of-office blood pressure (BP) at HAs. This study aimed to evaluate the differences in ambulatory BP parameters between untreated hypertensives at high and low altitudes and explore the influencing factors. DESIGN: This was a cross-sectional, case-control study. SETTING: Participants were recruited from 15 hospitals in Tibetan HAs and low altitudes in Sichuan Province, Southwest China. PARTICIPANTS: A total of 755 participants were eligible prior to matching, among whom 209 untreated hypertensive patients in each group were matched using 1:1 propensity score matching, with low altitudes/HAs as grouping variables (55.71±10.79 years, 55.7% male). PRIMARY AND SECONDARY OUTCOME MEASURES: The differences in ambulatory BP parameters between untreated hypertensives at high and low altitudes, and the influencing factors. RESULTS: Compared with patients at low altitudes, multivariate linear regression analysis revealed that the 24-hour and night-time diastolic BP (DBP) of patients at HAs increased by 2.16 mm Hg (95% CI 0.12 to 4.19), p=0.04, and 2.89 mm Hg (95% CI 0.49 to 5.30), p=0.02, respectively; the 24-hour and night-time DBP loads increased by 6.40% (95% CI 2.38% to 10.42%), p=0.002 and 4.14% (95% CI 0.23% to 8.05%), p=0.04, respectively. Mediation effect analysis revealed that 22% (95% CI 5.00% to 81.00%), p=0.01 of the increase in night-time DBP was mediated by night-time pulse rate (PR). However, the mediating effect of haemoglobin was relatively weak (5%, p=0.73). CONCLUSION: Compared with patients at low altitudes, with no difference in the risk of 10-year Framingham cardiovascular disease, the night-time DBP of hypertensive patients in HAs was significantly greater, which was mediated through an increased night-time PR. This difference may be related to the increased nocturnal sympathetic excitability in hypertensives at HAs. TRIAL REGISTRATION NUMBER: ChiCTR2200059719.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。